Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure.

Merkler AE, Chen ML, Parikh NS, Murthy SB, Yaghi S, Goyal P, Okin PM, Karas MG, Navi BB, Iadecola C, Kamel H.

Stroke. 2019 Feb 12:STROKEAHA118023622. doi: 10.1161/STROKEAHA.118.023622. [Epub ahead of print]

PMID:
30744541
2.

Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study.

Stokke IM, Li ZB, Cicala S, Okin PM, Kjeldsen SE, Devereux RB, Wachtell K.

Blood Press. 2019 Jan 30:1-9. doi: 10.1080/08037051.2019.1569463. [Epub ahead of print]

PMID:
30698038
3.

Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.

Okin PM, Kjeldsen SE, Devereux RB.

J Hypertens. 2019 Mar;37(3):629-635. doi: 10.1097/HJH.0000000000001915.

PMID:
30676480
4.

Arterial thromboembolic events preceding the diagnosis of cancer in older persons.

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, Panageas KS, DeAngelis LM.

Blood. 2018 Dec 21. pii: blood-2018-06-860874. doi: 10.1182/blood-2018-06-860874. [Epub ahead of print]

PMID:
30578253
5.

Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction.

Merkler AE, Diaz I, Wu X, Murthy SB, Gialdini G, Navi BB, Yaghi S, Weinsaft JW, Okin PM, Safford MM, Iadecola C, Kamel H.

J Am Heart Assoc. 2018 Nov 20;7(22):e010782. doi: 10.1161/JAHA.118.010782.

6.

Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.

Kampaktsis PN, Ullal AV, Swaminathan RV, Minutello RM, Kim L, Bergman GS, Feldman DN, Singh H, Wong SC, Okin PM.

Clin Cardiol. 2018 Sep;41(9):1246-1251. doi: 10.1002/clc.23034. Epub 2018 Aug 21.

7.

Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study.

Moon KA, Zhang Y, Guallar E, Francesconi KA, Goessler W, Umans JG, Best LG, Howard BV, Devereux RB, Okin PM, Navas-Acien A.

Environ Pollut. 2018 Sep;240:894-902. doi: 10.1016/j.envpol.2018.04.129. Epub 2018 May 26.

PMID:
29793197
8.

New diagnosis of cancer and the risk of subsequent cerebrovascular events.

Navi BB, Howard G, Howard VJ, Zhao H, Judd SE, Elkind MSV, Iadecola C, DeAngelis LM, Kamel H, Okin PM, Gilchrist S, Soliman EZ, Cushman M, Muntner P.

Neurology. 2018 Jun 5;90(23):e2025-e2033. doi: 10.1212/WNL.0000000000005636. Epub 2018 May 4.

PMID:
29728524
9.

Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).

Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR, Kronmal RA, Soliman EZ, Longstreth WT Jr.

Stroke. 2018 Apr;49(4):980-986. doi: 10.1161/STROKEAHA.117.020059. Epub 2018 Mar 13.

PMID:
29535268
10.

Reply: Arterial Thromboembolism in Non-Hodgkin Lymphoma, as the Presentation of Occult Cancer, and With Cancer Therapies.

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM.

J Am Coll Cardiol. 2018 Jan 16;71(2):260-262. doi: 10.1016/j.jacc.2017.10.088. No abstract available.

11.

Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.

Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K.

J Am Heart Assoc. 2017 Nov 27;6(12). pii: e006709. doi: 10.1161/JAHA.117.006709.

13.

Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome.

Yang H, Marwick TH, Wang Y, Nolan M, Negishi K, Khan F, Okin PM.

ESC Heart Fail. 2017 Nov;4(4):417-431. doi: 10.1002/ehf2.12151. Epub 2017 Apr 12.

14.

Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.

Okin PM, Hille DA, Kjeldsen SE, Devereux RB.

J Am Heart Assoc. 2017 Nov 18;6(11). pii: e007564. doi: 10.1161/JAHA.117.007564.

15.

Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.

Iribarren C, Round AD, Lu M, Okin PM, McNulty EJ.

J Am Heart Assoc. 2017 Oct 5;6(10). pii: e004954. doi: 10.1161/JAHA.116.004954.

16.

Association Between Troponin Levels and Embolic Stroke of Undetermined Source.

Merkler AE, Gialdini G, Murthy SB, Salehi Omran S, Moya A, Lerario MP, Chong J, Okin PM, Weinsaft JW, Safford MM, Fink ME, Navi BB, Iadecola C, Kamel H.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e005905. doi: 10.1161/JAHA.117.005905.

17.

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.

Merkler AE, Gialdini G, Yaghi S, Okin PM, Iadecola C, Navi BB, Kamel H.

Stroke. 2017 Nov;48(11):3073-3077. doi: 10.1161/STROKEAHA.117.018501. Epub 2017 Sep 22.

18.

Achieving target SBP for lowering the risk of major adverse cardiovascular events in persons with diabetes mellitus.

Ó Hartaigh B, Szymonifka J, Okin PM.

J Hypertens. 2018 Jan;36(1):101-109. doi: 10.1097/HJH.0000000000001515.

PMID:
28832365
19.

Risk of Arterial Thromboembolism in Patients With Cancer.

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM.

J Am Coll Cardiol. 2017 Aug 22;70(8):926-938. doi: 10.1016/j.jacc.2017.06.047.

20.

Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.

Bang CN, Soliman EZ, Simpson LM, Davis BR, Devereux RB, Okin PM; ALLHAT Collaborative Research Group.

Am J Hypertens. 2017 Sep 1;30(9):914-922. doi: 10.1093/ajh/hpx067.

21.

Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study).

Deen JF, Rhoades DA, Noonan C, Best LG, Okin PM, Devereux RB, Umans JG.

Am J Cardiol. 2017 Jun 1;119(11):1757-1762. doi: 10.1016/j.amjcard.2017.02.048. Epub 2017 Mar 16.

PMID:
28416200
22.

Cryptogenic Stroke: Research and Practice.

Yaghi S, Bernstein RA, Passman R, Okin PM, Furie KL.

Circ Res. 2017 Feb 3;120(3):527-540. doi: 10.1161/CIRCRESAHA.116.308447. Review.

PMID:
28154102
23.

Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Ernst ME, Davis BR, Soliman EZ, Prineas RJ, Okin PM, Ghosh A, Cushman WC, Einhorn PT, Oparil S, Grimm RH Jr; ALLHAT Collaborative Research Group.

J Am Soc Hypertens. 2016 Dec;10(12):930-938.e9. doi: 10.1016/j.jash.2016.10.010. Epub 2016 Nov 9.

24.

Impact of achieved systolic blood pressure on renal function in hypertensive patients.

Okin PM, Kjeldsen SE, Devereux RB.

Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):271-276. doi: 10.1093/ehjqcco/qcw017.

PMID:
29474712
25.

52 Genetic Loci Influencing Myocardial Mass.

van der Harst P, van Setten J, Verweij N, Vogler G, Franke L, Maurano MT, Wang X, Mateo Leach I, Eijgelsheim M, Sotoodehnia N, Hayward C, Sorice R, Meirelles O, Lyytikäinen LP, Polašek O, Tanaka T, Arking DE, Ulivi S, Trompet S, Müller-Nurasyid M, Smith AV, Dörr M, Kerr KF, Magnani JW, Del Greco M F, Zhang W, Nolte IM, Silva CT, Padmanabhan S, Tragante V, Esko T, Abecasis GR, Adriaens ME, Andersen K, Barnett P, Bis JC, Bodmer R, Buckley BM, Campbell H, Cannon MV, Chakravarti A, Chen LY, Delitala A, Devereux RB, Doevendans PA, Dominiczak AF, Ferrucci L, Ford I, Gieger C, Harris TB, Haugen E, Heinig M, Hernandez DG, Hillege HL, Hirschhorn JN, Hofman A, Hubner N, Hwang SJ, Iorio A, Kähönen M, Kellis M, Kolcic I, Kooner IK, Kooner JS, Kors JA, Lakatta EG, Lage K, Launer LJ, Levy D, Lundby A, Macfarlane PW, May D, Meitinger T, Metspalu A, Nappo S, Naitza S, Neph S, Nord AS, Nutile T, Okin PM, Olsen JV, Oostra BA, Penninger JM, Pennacchio LA, Pers TH, Perz S, Peters A, Pinto YM, Pfeufer A, Pilia MG, Pramstaller PP, Prins BP, Raitakari OT, Raychaudhuri S, Rice KM, Rossin EJ, Rotter JI, Schafer S, Schlessinger D, Schmidt CO, Sehmi J, Silljé HHW, Sinagra G, Sinner MF, Slowikowski K, Soliman EZ, Spector TD, Spiering W, Stamatoyannopoulos JA, Stolk RP, Strauch K, Tan ST, Tarasov KV, Trinh B, Uitterlinden AG, van den Boogaard M, van Duijn CM, van Gilst WH, Viikari JS, Visscher PM, Vitart V, Völker U, Waldenberger M, Weichenberger CX, Westra HJ, Wijmenga C, Wolffenbuttel BH, Yang J, Bezzina CR, Munroe PB, Snieder H, Wright AF, Rudan I, Boyer LA, Asselbergs FW, van Veldhuisen DJ, Stricker BH, Psaty BM, Ciullo M, Sanna S, Lehtimäki T, Wilson JF, Bandinelli S, Alonso A, Gasparini P, Jukema JW, Kääb S, Gudnason V, Felix SB, Heckbert SR, de Boer RA, Newton-Cheh C, Hicks AA, Chambers JC, Jamshidi Y, Visel A, Christoffels VM, Isaacs A, Samani NJ, de Bakker PIW.

J Am Coll Cardiol. 2016 Sep 27;68(13):1435-1448. doi: 10.1016/j.jacc.2016.07.729.

26.

Cranial Magnetic Resonance Imaging in Elderly American Indians: Design, Methods, and Implementation of the Cerebrovascular Disease and Its Consequences in American Indians Study.

Suchy-Dicey AM, Shibata D, Best LG, Verney SP, Longstreth WT Jr, Lee ET, Okin PM, Devereux R, O'Leary M, Ali T, Jensen PN, Muller C, Nelson LA, Rhoades E, Madhyastha T, Grabowski TJ, Beauchamp N, Umans JG, Buchwald D.

Neuroepidemiology. 2016;47(2):67-75. Epub 2016 Sep 8.

27.

Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study.

Tanoue MT, Kjeldsen SE, Devereux RB, Okin PM.

Blood Press. 2017 Apr;26(2):94-101. doi: 10.1080/08037051.2016.1215765. Epub 2016 Aug 9.

PMID:
27601135
28.

An age-old test in old age: ECG left ventricular hypertrophy and cardiovascular outcomes in the elderly.

Wachtell K, Okin PM.

J Hypertens. 2016 Nov;34(11):2145-6. doi: 10.1097/HJH.0000000000001107. No abstract available.

PMID:
27584974
29.

Arterial Stiffness Predicts Incident Atrial Fibrillation in the Framingham Heart Study: A Mechanistic Contribution in People With High Blood Pressure or History of Hypertension.

Kjeldsen SE, Aksnes TA, Wachtell K, Okin PM.

Hypertension. 2016 Sep;68(3):555-7. doi: 10.1161/HYPERTENSIONAHA.116.07671. Epub 2016 Jul 25. No abstract available.

PMID:
27456524
30.

Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy.

Okin PM, Kamel H, Kjeldsen SE, Devereux RB.

J Hypertens. 2016 Sep;34(9):1831-7. doi: 10.1097/HJH.0000000000000989.

PMID:
27254312
31.

Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy.

Tanoue MT, Kjeldsen SE, Devereux RB, Okin PM.

Blood Press. 2016 Dec;25(6):364-372. Epub 2016 May 5.

PMID:
27146272
32.

Community Screening for Nonischemic Cardiomyopathy in Asymptomatic Subjects ≥65 Years With Stage B Heart Failure.

Yang H, Wang Y, Nolan M, Negishi K, Okin PM, Marwick TH.

Am J Cardiol. 2016 Jun 15;117(12):1959-65. doi: 10.1016/j.amjcard.2016.03.045. Epub 2016 Apr 6.

PMID:
27138184
33.

Does electrocardiography still have a place in hypertension?

Bang CN, Okin PM.

J Hypertens. 2016 May;34(5):842-4. doi: 10.1097/HJH.0000000000000905. No abstract available.

PMID:
27027380
34.

Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.

Kamel H, Okin PM, Elkind MS, Iadecola C.

Stroke. 2016 Mar;47(3):895-900. doi: 10.1161/STROKEAHA.115.012004. Epub 2016 Jan 19. Review. No abstract available.

35.

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K.

Am J Cardiol. 2015 Dec 15;116(12):1840-4. doi: 10.1016/j.amjcard.2015.09.026. Epub 2015 Oct 3.

PMID:
26602073
36.

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H.

Hypertension. 2015 Dec;66(6):1123-9. doi: 10.1161/HYPERTENSIONAHA.115.06236. Epub 2015 Oct 12.

37.

Demographic Differences in Catheter Ablation After Hospital Presentation With Symptomatic Atrial Fibrillation.

Kummer BR, Bhave PD, Merkler AE, Gialdini G, Okin PM, Kamel H.

J Am Heart Assoc. 2015 Sep 22;4(9):e002097. doi: 10.1161/JAHA.115.002097.

38.

Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.

Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MS.

Stroke. 2015 Nov;46(11):3208-12. doi: 10.1161/STROKEAHA.115.009989. Epub 2015 Sep 22.

39.

Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy.

Vishram JK, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Mancia G, Okin PM, Rothwell PM, Wachtell K, Olsen MH.

J Hypertens. 2015 Dec;33(12):2422-30. doi: 10.1097/HJH.0000000000000739.

PMID:
26378687
40.

Fatty acids linked to cardiovascular mortality are associated with risk factors.

Ebbesson SO, Voruganti VS, Higgins PB, Fabsitz RR, Ebbesson LO, Laston S, Harris WS, Kennish J, Umans BD, Wang H, Devereux RB, Okin PM, Weissman NJ, MacCluer JW, Umans JG, Howard BV.

Int J Circumpolar Health. 2015 Aug 12;74:28055. doi: 10.3402/ijch.v74.28055. eCollection 2015.

41.

Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study.

Kamel H, O'Neal WT, Okin PM, Loehr LR, Alonso A, Soliman EZ.

Ann Neurol. 2015 Nov;78(5):670-8. doi: 10.1002/ana.24482. Epub 2015 Aug 31.

42.

Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients.

Okin PM, Kjeldsen SE, Devereux RB.

Stroke. 2015 Aug;46(8):2113-8. doi: 10.1161/STROKEAHA.115.009592. Epub 2015 Jun 18.

PMID:
26089332
43.

Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.

Okin PM, Hille DA, Larstorp AC, Wachtell K, Kjeldsen SE, Dahlöf B, Devereux RB.

Hypertension. 2015 Aug;66(2):368-73. doi: 10.1161/HYPERTENSIONAHA.115.05728. Epub 2015 Jun 8.

PMID:
26056336
44.

Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.

Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ.

Future Cardiol. 2015 May;11(3):323-31. doi: 10.2217/fca.15.22. Review.

45.

Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.

J Hypertens. 2015 Jul;33(7):1480-6. doi: 10.1097/HJH.0000000000000559.

PMID:
25799208
46.

Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study.

Kamel H, Bartz TM, Longstreth WT Jr, Okin PM, Thacker EL, Patton KK, Stein PK, Gottesman RF, Heckbert SR, Kronmal RA, Elkind MS, Soliman EZ.

Stroke. 2015 Mar;46(3):711-6. doi: 10.1161/STROKEAHA.114.007762. Epub 2015 Feb 12.

47.

Fatty acids linked to cardiovascular mortality are associated with risk factors.

Ebbesson SOE, Voruganti VS, Higgins PB, Fabsitz RR, Ebbesson LO, Laston S, Harris WS, Kennish J, Umans BD, Wang H, Devereux RB, Okin PM, Weissman NJ, MacCluer JW, Umans JG, Howard BV.

Int J Circumpolar Health. 2015 Jan;74(1):28055. doi: 10.3402/ijch.v74.28055.

PMID:
28417827
48.

Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis.

Rodriguez CJ, Soliman EZ, Alonso A, Swett K, Okin PM, Goff DC Jr, Heckbert SR.

Ann Epidemiol. 2015 Feb;25(2):71-6, 76.e1. doi: 10.1016/j.annepidem.2014.11.024. Epub 2014 Nov 28.

49.

Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.

Int J Cardiol. 2015 Feb 1;180:122-8. doi: 10.1016/j.ijcard.2014.11.181. Epub 2014 Nov 26.

PMID:
25438232
50.

The long and short of the PR-interval: relation to cardiovascular outcome in patients with coronary heart disease.

Bang CN, Okin PM.

Europace. 2015 Jun;17(6):838-9. doi: 10.1093/europace/euu284. Epub 2014 Oct 26. No abstract available.

PMID:
25345829

Supplemental Content

Support Center